Briggs Morrison is the founder of Syndax Pharmaceuticals. Backed by Domain Associates, MPM Capital, RMI Investments. Based in Waltham, Massachusetts.
Briggs W. Morrison, M.D., is the former President and Head of Drug Development at Syndax Pharmaceuticals, having transitioned from AstraZeneca R&D. He previously held the CEO position at Crossbow Therapeutics, where he also serves as Board Chair. At Syndax, he led the company, and at AstraZeneca, he advanced entinostat into Phase III studies for breast cancer.
Full founder directory · Investor directory · Company funding database · Fundraising library